Advertisement

Assay of Anti-Endotoxin Antibodies

  • Lore Brade
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 36)

Abstract

Lipopolysaccharides (LPS) constitute components of the outer membrane of Gram-negative bacteria. Chemically, they consist of a heteropolysaccharide and a covalently linked lipid, termed lipid A. The polysaccharide region is made up of the O-specific chain (built from repeating units of three to eight sugars) and the core part, divided into the inner core (the part linked to the lipid) and the outer core (the part linked to the O-specific chain). LPSs possessing an O-specific chain are called smooth LPS (S-LPS), those not having an O-chain are termed rough (R-LPS). The latter type of LPS may be observed in mutants that have lost the ability to synthesize the O-chain, or in wild-type bacteria without known genetic defect. LPS also represent the endotoxin of Gram-negative bacteria. In mammals, including humans, LPS exhibits a variety of biological effects that may be beneficial if administered in low amounts but harmful when present in higher concentrations as in the case of Gram-negative infection and Gram-negative septicemia.

Keywords

Outer Core Bordetella Pertussis Jackson Immuno Research Background Reactivity Checkerboard Titration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Rietschel, E. T., Brade, H., Holst, O., Brade, L., Müller-Loennies, S., Mamat, U., Zähringer, U., Beckmann, F., Seydel, U., Brandenburg, K., Ulmer, A. J., Mattern, T., Heine, H., Schletter, J., Loppnow, H., Schönbeck, U., Flad, H.-D., Hauschildt, S., Schade, U. F., Di Padova, F., Kusumoto, S., and Schumann, R. R. (1996) Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification, in Current Topics in Microbiology and Immunology, Pathology of Septic Shock (Rietschel, E. T. and Wagner, H., eds.), Springer-Verlag, Berlin, Germany, pp. 39–81.Google Scholar
  2. 2.
    Galanos, C, Freudenberg, M. A., Jay, F., Nerkar, D., Veleva, K., Brade, H., and Strittmatter, W. (1984) Immunogenic properties of lipid A. Rev. Infect. Dis. 6, 546–552.PubMedGoogle Scholar
  3. 3.
    Galanos, C, Lüderitz, O., and Westphal, O. (1971) Preparation and properties of antisera against the lipid A component of bacterial lipopolysaccharides. Eur. J. Biochem. 24, 116–122.CrossRefPubMedGoogle Scholar
  4. 4.
    Brade, L. and Brade, H. (1985) Characterization of two different antibody specificities recognizing distinct antigenic determinants in free lipid A of Escherichia coli. Infect. Immun. 48, 776–781.PubMedGoogle Scholar
  5. 5.
    Brade, L., Rietschel, E. T., Kusumoto, S., Shiba, T., and Brade, H. (1986) Immunogenicity and antigenicity of synthetic Escherichia coli lipid A. Infect. Immun. 51, 110–114.PubMedGoogle Scholar
  6. 6.
    Brade, L., Rietschel, E. T., Kusumoto, S., Shiba, T., and Brade, H. (1987) Immunogenicity and antigenicity of natural and synthetic Escherichia coli lipid A. Prog. Clin. Biol. Res. 231, 75–97.PubMedGoogle Scholar
  7. 7.
    Brade, L., Brandenburg, K., Kuhn, H.-M., Kusumoto, S., Macher, I., Rietschel, E. T., and Brade, H. (1987) The immunogenicity and antigenicity of lipid A are influenced by its physicochemical state and environment. Infect. Immun. 55, 2636–2644.PubMedGoogle Scholar
  8. 8.
    Di Padova, F. E., Brade, H., Barclay, R., Poxton, I. R., Liehl, E., Schuetze, E., Kocher, H. P., Ramsay, G., Schreier, M. H., McClelland, D. B. L., and Rietschel, E. T. (1993) A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides. Infect. Immun. 61, 3863–3872.PubMedGoogle Scholar
  9. 9.
    Bailat, S., Heumann, D., Le Roy, D., Baumgartner, J. D., Rietschel, E. T., Glauser, M. P., and Di Padova, F. (1997) Similarities and disparities between core-specific and O-side-chain-specific antilipopolysaccharide monoclonal antibodies in models of endotoxemia and bacteremia in mice. Infect. Immun. 65, 811–814.PubMedGoogle Scholar
  10. 10.
    Galanos, C. and Lüderitz, O. (1975) Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms. Eur. J. Biochem. 54, 603–610.CrossRefPubMedGoogle Scholar
  11. 11.
    Kuhn, H.-M., Brade, L., Appelmelk, B. J., Kusumoto, S., Rietschel, E. T., and Brade, H. (1992) Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A. Infect. Immun. 60, 2201–2210.PubMedGoogle Scholar
  12. 12.
    Kuhn, H.-M., Brade, L., Appelmelk, B. J., Kusumoto, S., Rietschel, E. T., and Brade, H. (1993) The antibody reactivity of monoclonal lipid A antibodies is influenced by the acylation pattern of lipid A and the assay system employed. Immunobiology 189, 457–471.PubMedGoogle Scholar
  13. 13.
    Brade, L., Engel, R., Christ, W. J., and Rietschel, E. T. (1997) A nonsubstituted primary hydroxyl group in position 6′ of free lipid A is required for binding of lipid A monoclonal antibodies. Infect. Immun. 65, 3961–3965.PubMedGoogle Scholar
  14. 14.
    Süsskind, M., Brade, L., Brade, H., and Holst, O. (1997) Identification of a novel heptoglycan of α→2-linked D-glycero-D-manno-heptopyranose. Chemical and antigenic structure of lipopolysaccharides from Klebsiella pneumoniae ssp. pneumoniae rough strain R20 (01:K20). J. Biol. Chem. 273, 7006–7017.CrossRefGoogle Scholar
  15. 15.
    Kuhn, H.-M. (1993) Cross-reactivity of monoclonal antibodies and sera directed against lipid A and lipopolysaccharides. Infection 21, 179–186.CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2000

Authors and Affiliations

  • Lore Brade
    • 1
  1. 1.Research Center BorstelCenter for Medicine and BiosciencesBorstelGermany

Personalised recommendations